Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News AiRo Digital Labs acquires Cloudaction to boost AI and cloud consulting capabilities In a significant development in the technology consulting sector, AiRo Digital Labs (AiRo), a leader in AI and… byPallavi MadhirajuApril 19, 2024